Aixalà et al. (2018). Psychedelics and personality. ACS Chemical Neuroscience.
Anderson, Lake & Walterfang (2018). The trip of a lifetime: hallucinogen persisting perceptual disorder. Australasian Psychiatry.
Barnett, Siu & Pope (2018). A survey of American psychiatrists’ attitudes toward classic hallucinogen. The Journal of Nervous and Mental Disease.
Belouin & Henningfield (2018). Psychedelics: Where we are now, why we got here, what we must do. Neuropharmacology.
Bouso et al. (2018). Serotonergic psychedelics and personality: A systematic review of contemporary research. Neuroscience and Biobehavioral Reviews.
Bragazzi et al. (2018). Ancient shamanism and modern psychotherapy: from anthropology to evidence-based psychedelic medicine. Cosmos and History: The Journal of Natural and Social Philosophy.
Bright & Williams (2018). Should australian psychology consider enhancing psychotherapeutic interventions with psychedelic drugs? A call for research. Australian Psychologist.
Byock (2018). Taking psychedelics seriously. Journal of Palliative Medicine.
Carhart-Harris (2018). The entropic brain - revisited. Neuropharmacology.
Carhart-Harris et al. (2018). Psychedelics and the essential importance of context. Journal of Psychopharmacology.
Carhart-Harris (2018). Serotonin, psychedelics and psychiatry. World Psychiatry.
Carthart-Harris (2018). Psychedelics and connectedness. Psychopharmacology.
Caspar et al. (2018). Development of a quantitative approach in blood plasma for low-dosed hallucinogens and opioids using LC-high resolution mass spectrometry. Talanta.
Cavanna et al. (2018). Dynamic functional connectivity and brain metastability during altered states of consciousness. NeuroImage.
Curran, Nutt & de Wit (2018). Psychedelics and related drugs: therapeutic possibilities, mechanisms and regulation. Psychopharmacology.
Dell’Erba, Brown & Proulx (2018). Synesthetic hallucinations induced by psychedelic drugs in a congenitally blind man. Consciousness and Cognition
Dyck & Farrell (2018). Psychedelics and psychotherapy in Canada: Humphry Osmond and Aldous Huxley. History of Psychology.
Elmore et al. (2018). Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats. Neuropharmacology.
Enos (2018). Psychedelics gradually gaining attention as potential mental health therapies. Alcoholism & Drug Abuse Weekly.
Fattore et al. (2018). Psychedelics and reconsolidation of traumatic and appetitive maladaptive memories: Focus on cannabinoids and ketamine. Psychopharmacology.
Fernández-Calderón, Cleland & Palamar (2018). Polysubstance use profiles among electronic dance music party attendees in New York City and their relation to use of new psychoactive substances. Addictive Behaviors.
Hartogsohn (2018). The meaning-enhancing properties of psychedelics and their mediator role in psychedelic therapy, spirituality, and creativity. Frontiers in Neuroscience.
Heal, Gosden & Smith (2018). Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humans. Neuropharmacology.
Hendricks et al. (2018). The relationships of classic psychedelic use with criminal behavior in the United States adult population. Journal of Psychopharmacology.
Horváth, Szummer & Szabo (2018). Weak phantasy and visionary phantasy: The phenomenological significance of altered states of consciousness. Phenomenology and the Cognitive Sciences.
Jungaberle et al. (2018). Positive psychology in the investigation of psychedelics and entactogens: A critical review. Neuropharmacology.
Kaelen et al. (2018). The hidden therapist: Evidence for a central role of music in psychedelic therapy. Psychopharmacology.
Kaelen et al. (2018). "The hidden therapist: Evidence for a central role of music in psychedelic therapy": Correction. Psychopharmacology.
Kuypers (2018). Out of the box: A psychedelic model to study the creative mind. Medical Hypotheses.
La Mohr et al. (2018). Use of synthetic stimulants and hallucinogens in a cohort of electronic dance music festival attendees. Forensic Science International.
Lemercier & Terhune (2018). Psychedelics and hypnosis: Commonalities and therapeutic implications. Journal of Psychopharmacology.
Luethi & Liechti (2018). Monoamine transporter and receptor interaction profiles in vitro predict reported human doses of novel psychoactive stimulants and psychedelics. The International Journal of Neuropsychopharmacology.
Ly et al. (2018). Psychedelics promote structural and functional neural plasticity. Cell Reports.
Marek & Ramos (2018). β-adrenergic receptor activation suppresses the rat phenethylamine hallucinogen-induced head twitch response: hallucinogen-induced excitatory post-synaptic potentials as a potential substrate. Frontiers in Pharmacology.
Martinotti et al. (2018). Hallucinogen persisting perception disorder: etiology, clinical features, and therapeutic perspectives. Brain Sciences.
Martín-González et al. (2018). Do psychoactive drugs have a therapeutic role in compulsivity? Studies on schedule-induced polydipsia. Psychopharmacology.
Michaels et al. (2018). Inclusion of people of color in psychedelic-assisted psychotherapy: A review of the literature. BMC Psychiatry.
Milliere et al. (2018). Psychedelics, meditation, and self-consciousness. Frontiers in Psychology.
Mohr et al. (2018). Use of synthetic stimulants and hallucinogens in a cohort of electronic dance music festival attendees. Forensic Science International.
Neitzke-Spruill & Glasser (2018). A gratuitous grace: The influence of religious set and intent on the psychedelic experience. Journal of Psychoactive Drugs.
Nielson et al. (2018). The psychedelic debriefing in alcohol dependence treatment: illustrating key change phenomena through qualitative content analysis of clinical sessions. Frontiers in Pharmacology.
Noorani et al. (2018). Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts. Journal of Psychopharmacology.
Orsolini et al. (2018). Psychedelic fauna for psychonaut hunters: a mini-review. Frontiers in Psychiatry.
Reiche et al. (2018). Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review. Progress in Neuro-Psychopharmacology & Biological Psychiatry.
Sanz & Tagliazucchi (2018). The experience elicited by hallucinogens presents the highest similarity to dreaming within a large database of psychoactive substance reports. Frontiers in Neuroscience.
Sanz et al. (2018). Corrigendum: The experience elicited by hallucinogens presents the highest similarity to dreaming within a large database of psychoactive substance reports. Frontiers in Neuroscience.
Schenberg (2018). Psychedelic-assisted psychotherapy: a paradigm shift in psychiatric research and development. Frontiers in Pharmacology.
Schindler et al. (2018). Neuroendocrine associations underlying the persistent therapeutic effects of classic serotonergic psychedelics. Frontiers in Pharmacology.
Sellers & Leiderman (2018). Psychedelic drugs as therapeutics: no illusions about the challenges. Clinical Pharmacology and Therapeutics.
Sessa (2018). The 21st century psychedelic renaissance: Heroic steps forward on the back of an elephant. Psychopharmacology.
Swanson (2018). Unifying theories of psychedelic drug effects. Frontiers in Pharmacology.
Thiessen et al. (2018). Psychedelic use and intimate partner violence: The role of emotion regulation. Journal of Psychopharmacology.
Timmermann et al. (2018). DMT Models the Near-Death Experience. Frontiers in Psychology.
Vinhosa et al. (2018). Comparing the detection of endogenous psychedelics in individuals with and without alleged mediumistic experiences. EXPLORE.
Walters et al. (2018). Substance use, anxiety, and depressive symptoms among college students. Journal of Child & Adolescent Substance Abuse.